600479.SH
千金药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.80
+0.41%Margins
Gross margin
49.2%
EBITDA margin
14.8%
EBIT margin
12.6%
Net margin
8.6%
FCF margin
10.0%
9.9%
Return on equity
6.0%
Return on assets
14.4%
Return on invested capital
0.71x
Asset turnover
CNY 503.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026